About 10 percent of patients with chronic lymphocytic leukemia discontinued therapy with the Bruton tyrosine kinase inhibitor drug ibrutinib because of disease progression during clinical trials, according to a new study.
from Top Health News — ScienceDaily http://bit.ly/1BKjJJN via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1ayj7uE
No comments:
Post a Comment